Long-COVID is a new emerging syndrome worldwide that is characterized by the persistence
of unresolved signs and symptoms of COVID-19 more than 4 weeks after the infection and …

HIV-1 can infect both activated and resting, non-dividing cells, following which the viral genome
can be permanently integrated into a host cell chromosome. Latent HIV-1 reservoirs are …

Main cause of severe illness and death in COVID-19 patients appears to be an excessive
but ineffectual inflammatory immune response that may cause severe acute respiratory …

Infection by novel coronavirus SARS-CoV-2 causes different presentations of COVID-19
and some patients may progress to a critical, fatal form of the disease that requires their …

SARS-CoV-2 infection causes COVID-19, ranging from mild to critical disease in symptomatic
subjects. It is essential to better understand the immunologic responses occurring in …

HIV-1 post-integration latency in CD4+ lymphocytes is responsible for viral persistence despite
treatment, but mechanisms involved in the establishment of latent viral reservoirs are not …

Massive activation of infected CD4+ T cells during acute HIV-1 infection leads to reservoir
seeding and T-cell destruction. During T-cell activation, the antiviral effect of the innate factor …

Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID
approximately three months after initial infection. These symptoms are highly variable, and the …

A potential strategy to cure HIV-1 infection is to use latency reversing agents (LRAs) to
eliminate latent reservoirs established in resting CD4+ T (rCD4+) cells. As no drug has been …

The human immunodeficiency virus type 1 (HIV-1) regulator Tat is essential for viral replication
because it achieves complete elongation of viral transcripts. Tat can be released to the …